![Kenneth Huttner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Huttner
Plus aucun poste en cours
Profil
Kenneth Huttner worked as a Fellow at the National Institute of Child Health & Human Development from 1985 to 1988.
He then worked as a Medical Director at Interleukin Genetics, Inc. and as a Medical Director at CombinatoRx, Inc. from 2007 to 2009.
He worked as a Vice President-Clinical Development at Edimer Pharmaceuticals, Inc. from 2010 to 2015.
He also worked as an Executive Director-Translation Medicine at Novartis Institutes for Biomedical Research, Inc. from 2015 to 2017 and as a Vice President-Clinical Development at Bioverativ, Inc. from 2017 to 2019.
From 2019 to 2020, he worked as a Senior Vice President & Head-Clinical Development at LogicBio Therapeutics, Inc. Dr. Huttner earned a doctorate degree from Yale University.
Anciens postes connus de Kenneth Huttner
| Sociétés | Poste | Fin |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2020 |
| BIOVERATIV INC | Directeur Technique/Scientifique/R&D | 01/02/2019 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/07/2017 |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Directeur Technique/Scientifique/R&D | 28/02/2015 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Formation de Kenneth Huttner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
National Institute of Child Health & Human Development
 National Institute of Child Health & Human Development General GovernmentGovernment Conducts and supports basic and clinical research in maternal, child health and adults | Government |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
